Monocrotaline
CAS No. 315-22-0
Monocrotaline( Crotaline | MCT | NSC 28693 )
Catalog No. M14021 CAS No. 315-22-0
Extracted from Legume Crotalaria assamica;Suitability:Methanol,ethanol,chloroform;Store the product in sealed,cool and dry condition
Purity : >98% (HPLC)
COA
Datasheet
HNMR
HPLC
MSDS
Handing Instructions
| Size | Price / USD | Stock | Quantity |
| 25MG | 37 | In Stock |
|
| 50MG | 53 | In Stock |
|
| 100MG | 80 | In Stock |
|
| 200MG | 116 | In Stock |
|
| 500MG | 196 | In Stock |
|
| 1G | 287 | In Stock |
|
Biological Information
-
Product NameMonocrotaline
-
NoteResearch use only, not for human use.
-
Brief DescriptionExtracted from Legume Crotalaria assamica;Suitability:Methanol,ethanol,chloroform;Store the product in sealed,cool and dry condition
-
DescriptionExtracted from Legume Crotalaria assamica;Suitability:Methanol,ethanol,chloroform;Store the product in sealed,cool and dry condition.(In Vitro):Monocrotaline (MCT) is an 11-membered macrocyclic pyrrolizidine alkaloid (PA) derived from the seeds of the Crotalaria pallida plant. Monocrotaline a natural ligand exhibits dose-dependent cytotoxicity with potent antineoplastic activity. The in vitro cytotoxicity of monocrotaline is proved at IC50 24.966 μg/mL and genotoxicity at 2 X IC50 against HepG2 cells. (In Vivo):MCT causes a pulmonary vascular syndrome in rats characterized by proliferative pulmonary vasculitis, pulmonary hypertension (PH), and cor pulmonale. Among preclinical models of pulmonary arterial hypertension (PAH), monocrotaline animal model offers the advantage of mimic several key aspects of human PAH, including vascular remodeling, proliferation of smooth muscle cells, endothelial dysfunction, upregulation of inflammatory cytokines, and right ventricle failure, requiring a single drug injection. Changes in multiple pathways associated with the development of PH, including activated glycolysis, increased markers of proliferation, disruptions in carnitine homeostasis, increased inflammatory and fibrosis biomarkers, and a reduction in glutathione biosynthesis are observed with the injection of monocrotaline.
-
In VitroCell Viability Assay Cell Line:HepG2 cells Concentration:25, 50, 100 and 200 μg/mL Incubation Time:48 h Result:Induced apoptosis rate was dose-dependent.
-
In Vivo——
-
SynonymsCrotaline | MCT | NSC 28693
-
PathwayTGF-beta/Smad
-
TargetTGFBR
-
RecptorTGFβ
-
Research AreaMetabolic Disease
-
Indication——
Chemical Information
-
CAS Number315-22-0
-
Formula Weight325.36
-
Molecular FormulaC16H23NO6
-
Purity>98% (HPLC)
-
SolubilityDMSO: 10 mM
-
SMILESO=C(O[C@]1([H])CCN2[C@]1([H])C(CO3)=CC2)[C@H](C)[C@@](C)(O)[C@@](C)(O)C3=O
-
Chemical Name20-Norcrotalanan-11,15-dione, 14,19-dihydro-12,13-dihydroxy-, (13-alpha,14-alpha)- (9CI)
Shipping & Storage Information
-
Storage(-20℃)
-
ShippingWith Ice Pack
-
Stability≥ 2 years
Reference
1. Ahmed LA, et al. Eur J Pharmacol. 2014 Oct 5;740:379-87.
molnova catalog
related products
-
Kartogenin
Kartogenin is an activator of the smad4/smad5 pathway, and promotes the selective differentiation of multipotent mesenchymal stem cells into chondrocytes.
-
Pentabromophenol
Pentabromophenol suppressed TGF-β response by accelerating the turnover rate of TGF-β receptors.
-
A 83-01
A potent, selective TGF-beta type I receptor ALK-5, ALK-4 and ALK-7 inhibitor with IC50 of 12, 45 and 7.5 nM, respectively.
Cart
sales@molnova.com